Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Key Takeaways Activist investor Starboard Value reportedly has taken a large stake in consumer health care products maker ...

Activist investor Starboard Value has built a stake in consumer-products company Kenvue Inc., seeking changes that would ...

Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products maker ...

Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023, according to ...

Starboard Values Investment in Kenvue Inc. Activist hedge fund Starboard Value has taken a sizeable stake in Kenvue Inc., ...

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday. Citing unnamed ...

the Wall Street Journal reported on Sunday. Starboard has approached two former Pfizer executives -- Ian Read and Frank D’Amelio -- who have in turn expressed interest in helping, the WSJ report ...

AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.

Pharmaceutical giant Pfizer (PFE) is seeing stock gains in Monday's pre-market trading after activist investor Starboard Value took up a $1 billion stake, according to a Wall Street Journal report.

Activist investor Starboard Value seeks to turn around Pfizer with $1 billion stake, former executives involved.